Articles related to PREVENTIVE MEDICINE

In the BLUE-C trial, Cologuard Plus demonstrated a 93.9% sensitivity for colorectal cancer detection, significantly outperforming the 67.3% sensitivity of FIT.

N=1 science empowers patients to become “citizen scientists,” experimenting and refining their health choices to find what works best for their own bodies.

Current research on kombucha suggests potential benefits for gut health and blood sugar management, though human studies are limited. Physicians should be aware of its mild alcohol content and potential contraindications when discussing this beverage with patients.

Moderate caffeine intake (200-300 mg per day) was associated with a 40.7% lower risk of new-onset cardiometabolic multimorbidity compared to non-consumers or those consuming less than 100 mg daily.

Bempedoic acid reduced major adverse cardiovascular events by 13% compared to placebo in statin-intolerant patients, with efficacy comparable to statins when normalized for LDL-C reduction.

The Endocrine Society’s 2024 guidelines suggest against routine vitamin D screening and supplementation for most adults under 75, marking a significant shift in clinical practice recommendations.